有一篇文献用MRM 方法测定CYP3A4, 肽段是LSLGGLLQPEKPVVLK。文献上选择母离子 m/z=564.6, 子离子m/z=746。为什么母离子比子离子还大?难道是母离子电荷比子离子多?原文链接:http://www.sciencedirect.com/science/article/pii/S0006295214005838
原文方法如下:
The CYP protein quantification assays were performed on a triple-quadrupole $$lc-MS instrument (Agilent 6460A) coupled to an Agilent 1290 Infinity $$lc system (Agilent Technologies), in ESI positive ionization mode. Approximately 2 μg of the trypsin digest (5 μl) was injected onto the column (Kinetex 1.7 μ, C18 100A; 100 × 2.1 mm, Phenomenex, Torrance, CA). Mobile phases consisted of water (A) and acetonitrile (B) (both containing 0.1% formic acid) at a flow rate of 0.3 ml/min. The gradient was 3% mobile phase B for 2.0 min, followed by gradient elution program with mobile phase B concentration of 3 to 18% (2.0-4.0 min), 18 to 22% (4.0-8.0 min), 22 to 24% (8.0-10 min), 24% (10-12.2 min), 24 to 34% (12.2-12.5 min) and 34 to 38% (12.5-15.0 min). This was followed by washing with 80% mobile phase B for 0.9 min and re-equilibration for 4.9 min. Surrogate peptides and internal standards were monitored in multiple reaction monitoring (MRM) mode using instrument parameters provided in Table 1. HP$$lc-MS/MS data were processed using the MassHunter (Agilent Technologies) and Skyline software.
Table 1.
Optimized MS/MS parameters used for quantification of surrogate peptides and internal standards of CYP enzymes in trypsin digested microsomes.
Enzyme | Peptide | Precursor ion (m/z) | Product ion (m/z) | Fragmentor (V) | Collision energy (eV) | LLOQ (fmol on-column) |
CYP3A4 | LSLGGLLQPEKPVVLK | 564.6 | 746 | 100 | 9 | 0.3 |
| | 564.6 | 689.4 | 100 | 10 | |
| LSLGGLLQPEKPVVLK | 567.3 | 750 | 100 | 9 | |
| | 567.3 | 693.4 | 100 | 9 | |
CYP3A5 | DSIDPYIYTPFGTGPR | 900.0 | 995.7 | 130 | 28 | 1 |
| | 900.0 | 684.9 | 130 | 20 | |
| DSIDPYIYTPFGTGPR | 904.9 | 1005.5 | 130 | 28 | |
| | 904.9 | 689.9 | 130 | 28 | |
CYP3A7 | FNPLDPFVLSIK | 695.4 | 918.4 | 110 | 16 | 0.1 |
| | 695.4 | 564.7 | 110 | 16 | |
| FNPLDPFVLSIK | 699.4 | 926.5 | 110 | 16 | |
| | 699.4 | 568.8 | 110 | 16 | |
CYP2C9 | GIFPLAER | 451.9 | 585.4 | 75 | 7 | 0.15 |
| | 451.9 | 366.8 | 75 | 7 | |
| GIFPLAER | 456.8 | 595.3 | 75 | 7 | |
| | 456.8 | 371.7 | 75 | 7 | |
CYP2C19 | IYGPVFTLYFGLER | 838.0 | 1145.4 | 145 | 28 | 1 |
| | 838.0 | 998.3 | 145 | 28 | |
| IYGPVFTLYFGLER | 843.0 | 1155.6 | 145 | 28 | |
| | 843.0 | 1008.5 | 145 | 28 | |
CYP2A6 | GTGGANIDPTFFLSR | 777.1 | 982.5 | 130 | 22 | 0.4 |
| | 777.1 | 867.2 | 130 | 26 | |
| GTGGANIDPTFFLSR | 781.9 | 992.5 | 130 | 26 | |
| | 781.9 | 877.5 | 130 | 26 | |
CYP2D6 | GTTLITNLSSVLK | 673.9 | 974.4 | 110 | 16 | 0.6 |
| | 673.9 | 861.3 | 110 | 16 | |
| GTTLITNLSSVLK | 677.9 | 982.4 | 110 | 16 | |
| | 677.9 | 869.3 | 110 | 16 | |
CYP reductase | FAVFGLGNK | 476.9 | 734.3 | 100 | 9 | 0.05 |
| | 476.9 | 635.3 | 100 | 9 | |
| FAVFGLGNK | 480.8 | 742.4 | 100 | 9 | |
| | 480.8 | 643.4 | 100 | 9 | |
Underlined residues represent the internal standards with the labeled [
13C
615N
2]-lysine or [
13C
615N
4]-arginine.